Company intelligence
FenoMark Diagnostics AB
The best cancer treatment for all with robust, reliable and data rich proteomics on routinely biobanked FFPE tissue
Biotechnology Research
Solna, SE
2–10 employees
Founded 2019
2 public signals
About FenoMark Diagnostics AB
Dedicated to improving cancer care by developing better diagnostic assays for therapy selection.
Verified activity
Signals from FenoMark Diagnostics AB
2 published signals
Legal & Regulatory
FenoMark Diagnostics AB received Breakthrough Device Designation from the FDA for its blood test.
Reported by Santeri Kiviluoto
Research & Knowledge
FenoMark Diagnostics AB published the FIND trial in JCO on 29 July, which randomised 728 patients after colorectal cancer surgery to ctDNA-guided surveillance or standard imaging, detecting recurrence a median of 3.9 months earlier.
Reported by Santeri Kiviluoto